These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 19804450

  • 1. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis.
    Agostinis F, Forti S, Di Berardino F.
    Allergy; 2010 Mar; 65(3):410-1. PubMed ID: 19804450
    [No Abstract] [Full Text] [Related]

  • 2. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
    Wolthers OD, Høst A, Frederiksen B, Halken S.
    Ugeskr Laeger; 2012 Aug 27; 174(35):1989-92. PubMed ID: 22929576
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr 27; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
    Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, Knecht R, Stephan V, Tholstrup B, Weisshaar C, Kaiser F.
    J Allergy Clin Immunol; 2009 Jan 27; 123(1):167-173.e7. PubMed ID: 19130937
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis.
    Powell RJ, Frew AJ, Corrigan CJ, Durham SR.
    Allergy; 2007 Nov 27; 62(11):1335-8. PubMed ID: 17714551
    [Abstract] [Full Text] [Related]

  • 13. High-dose sublingual immunotherapy in children at 8-year follow-up.
    Leonardi S, Spicuzza L, La Rosa M.
    Ann Allergy Asthma Immunol; 2009 Mar 27; 102(3):259-60. PubMed ID: 19354077
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W.
    Allergy; 2004 May 27; 59(5):498-504. PubMed ID: 15080830
    [Abstract] [Full Text] [Related]

  • 17. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV, Hamelmann E, Zielen S, Kamin W, Bergmann KC, Sieder C, Stenglein S, Seyfried S, Wahn U, DUAL study group.
    Clin Exp Allergy; 2009 Feb 27; 39(2):271-9. PubMed ID: 19016798
    [Abstract] [Full Text] [Related]

  • 18. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.
    Pediatr Allergy Immunol; 2006 Sep 27; 17(6):396-407. PubMed ID: 16925684
    [Abstract] [Full Text] [Related]

  • 19. Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis.
    Patterson AM, Bonny AE, Shiels WE, Erwin EA.
    Ann Allergy Asthma Immunol; 2016 Feb 27; 116(2):168-70. PubMed ID: 26706294
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.